US Patent Issued to Lodestone Biomedical on April 21 for "Implantable biosensor containing a magnetic nanoparticle assay for in vivo analyte detection" (New Hampshire, Washington Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,607,692, issued on April 21, was assigned to Lodestone Biomedical Inc. (Lebanon, N.H.).

"Implantable biosensor containing a magnetic nanoparticle assay for in vivo analyte detection" was invented by Christian Knopke (Redmond, Wash.) and Solomon G. Diamond (Hanover, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The system disclosed comprises an apparatus and a method for the detection and quantification of targeted molecules in vivo. The apparatus comprises an implantable biosensor and an AC magnetic detection device. The implantable biosensor includes functionalized nanoparticles functionalized with one or more moieties that bind to a molecular t...